ARCHIVES

SPORE Eligibility, Cost Issues Clarified In Addendum To RFA

This article is from The Cancer Letter archive.

Vol. 17 No. 41 | October 25, 1991

Download PDF Visit The Full Archive

Related Articles

Evidence “Weak” Linking EMFs, cancer

June 25, 1999

Hammer Goes Public With Appeal for Increased Funding

March 14, 1986

T-Cell Vaccines Cut Time To Protective Immunity

November 25, 2005

In Brief: Megastrol Acetate Still Under FDA Review; Mays Hired For NCI’s Technology Office

July 20, 1990

Cancer Control: Incidence, Death Rates Continue To Fall, Annual Reports Says

April 23, 1999

Construction, Senior Biomedical Service Not In Legislation

November 4, 1988